prostate cancer index | prostate cancer | prostatectomy | radiation | hormone | cryosurgery | hifu | wait & see | alternative treatment | diet | articles | contact |

Archive for December, 2008

Why prostate cancer patients fail hormone deprivation therapy

Wednesday, December 31st, 2008 Posted in hormone therapy | No Comments »

Johns Hopkins scientists identify receptor type that makes cancer cells resistant to therapy, more aggressive The hormone deprivation therapy that prostate cancer patients often take gives them only a temporary fix, with tumors usually regaining their hold within a couple of ...

St. James offers new treatment for prostate cancer

Friday, December 26th, 2008 Posted in prostate cancer | No Comments »

A new scan could help tell the difference between aggressive prostate cancers and harmless slow-growing ones. A new procedure to combat prostate cancer is being performed at St. James Healthcare in Butte. Since 1992, Dr. John Stevenson has been performing brachytherapy, an ...

Noscapine - a natural substance that effectively treat advanced prostate cancer

Friday, December 26th, 2008 Posted in alternative treatments | No Comments »

Could a natural substance effectively treat advanced prostate cancer? And could clinical trials of that potential cure be thwarted because drug companies know they can't make money out of a treatment that can't be patented? The answer to both those ...

Researchers Found Cough Medicine Ingredient Could Effectively Treat Prostate Cancer

Sunday, December 21st, 2008 Posted in prostate cancer | No Comments »

A study published December 18 in the December issue of the European medical journal Anticancer Research demonstrates that an ingredient used in a common cough suppressant may be useful in treating advanced prostate cancer. Researchers found that noscapine, which has ...

The regional vagaries of Medicare coverage (in the USA)

Thursday, December 18th, 2008 Posted in Uncategorized | No Comments »

Although there are certainly unanswered questions about the effectiveness and safety of CyberKnife therapy in the long-term management of localized prostate cancer, it has one huge benefit over conventional radiotherapy for the patient who prefers the idea of external beam ...

Prostate cancer diagnosis more likely in low-income men

Wednesday, December 17th, 2008 Posted in prostate cancer diagnosis | No Comments »

Low-income men are more likely to present with advanced prostate cancers, most likely because they don't receive screening services shown to reduce the diagnosis of later-stage cancers, a UCLA study found. In an accompanying editorial, a health disparities researcher writes that ...

Double whammy treatment could halve prostate cancer deaths

Tuesday, December 16th, 2008 Posted in prostate cancer | No Comments »

A Scandinavian study confirms the effectiveness of using both radiation and hormone-blocking drugs in treating advanced prostate cancer. Study suggests that death rates among some prostate cancer patients could be halved by this new combo method of treating the disease. Researchers said ...

RapidArc is a major advance in radiotherapy technology

Monday, December 15th, 2008 Posted in radiation therapy | No Comments »

Mr McCormack, from Warrington in Cheshire, received the fast and efficient RapidArc therapy at Clatterbridge centre for Oncology in the Wirral, the first UK cancer centre to introduce the revolutionary new technique in prostate cancer treatment. Researchers suggests that RapidArc is ...

Prostate cancer diagnosis - Taking painkillers could lower readings of PSA

Thursday, December 11th, 2008 Posted in prostate cancer diagnosis | No Comments »

A new study reports that taking certain painkillers can lower the levels of prostate specific antigen (PSA) which can cause problems with the PSA screening tests used for prostate cancer detection. It is not known whether this has anything to do ...

Hormone therapy does not appear to increase cardiac deaths in prostate cancer patients

Thursday, December 11th, 2008 Posted in hormone therapy | No Comments »

Since the male hormones called androgens can accelerate the development of prostate cancer, reducing their activity is a standard part of treating the disease. Most commonly this is done with gonadotropin-releasing hormone agonists (GnRH) that block the production of all ...